Compare the complementary effect of radiofrequency ablation technique besides chemotherapy in patients with metastatic liver tumors from breast and control group under chemotherapy
Phase 2
- Conditions
- liver metastases from breast cancer.Secondary malignant neoplasm of other specified sites
- Registration Number
- IRCT2017010931062N2
- Lead Sponsor
- Research department, Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 52
Inclusion Criteria
liver metastatic lesion from breast tissue verified by pathology; liver metastatic lesion far from intrahepatic bile ducts; liver metastatic lesion far from great veins more than 3 cm
Exclusion criteria: Acute febrile infection; Cr>2; Ascites; hepatic encephalopathy; INR>1.5; Bill>3; verified extrahepatic metastases; surgery candidates
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ?The status of residual liver tumour. Timepoint: 3 weeks after treatment, 3 months and 6 months after treatment. Method of measurement: Evaluate CT scan images with and without contrast.;Liver tomur size. Timepoint: 3 weeks after treatment, 3 months and 6 months after treatment. Method of measurement: Evaluate CT scan images with and without contrast.;Frequency of liver tumors. Timepoint: 3 weeks after treatment, 3 months and 6 months after treatment. Method of measurement: Evaluate CT scan images with and without contrast.;Contrast agent absorption by liver tumor. Timepoint: 3 weeks after treatment, 3 months and 6 months after treatment. Method of measurement: Evaluate CT scan images with and without contrast.
- Secondary Outcome Measures
Name Time Method